Sotagliflozin Bioequivalence Study

NCT03211195 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sotagliflozin (SAR439954)

Sponsor

Sanofi